Download - SlideBoom

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Pharmaceutical marketing wikipedia , lookup

Plateau principle wikipedia , lookup

Psychopharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Orphan drug wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Compounding wikipedia , lookup

Theralizumab wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Neuropharmacology wikipedia , lookup

Bad Pharma wikipedia , lookup

Drug design wikipedia , lookup

Medication wikipedia , lookup

Prescription costs wikipedia , lookup

Pharmacognosy wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Drug interaction wikipedia , lookup

Drug discovery wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Transcript
Self micro emulsified
drug delivery system
Presented by
T.SHIVAKUMAR,STEPHEN.K
IV YEAR I SEM
KOTTAM INSTITUTE OF
PHARMACY
WHAT IS SMEDDS
 SMEEDS is mixture of oils, surfactants,
and cosurfactants, which are
emulsified in aqueous media under
conditions of gentle agitation of
digestive motility that would be
encountered in the gastro intestinal
(GI) tract.
AIM
 Most of the new drug candidates in
development today are sparingly
soluble and associated with poor
bioavailability
 The main purpose is to prepare
SMEDDS for oral bioavailability
enhancement of a poorly water soluble
drug
Bio pharmaceutical classification system
 according to bio pharmaceutical
classification system(BCS) the classII
drugs have poor solubility and high
permeability , thus the rate limiting
process of absorption is the drug
dissolution step. Formulation plays the
major role in improving the rate and
extent of absorption of such drugs from GI
tract.
Present study
 In the present study, an attempt was
made to enhance the solubility and in
vitro dissolution of candesartan
cilexetil byformulating it as SMEDDS
for filling into hard gelatin capsules.
Drug profile
 Candesartan Cilexetil a prodrug is
hydrolyzed to candesartan during
absorption from the gastrointestinal
tract., practically insoluble in water.
 Category: Antihypertensive Agents
 Subcategory: Angiotensin II Receptor
Antagonist
Structure
Materials
 Drug- Candesartan cilexetile Oil -Miglyol 812
 Surfactants- Cremophor EL &Tween 80
 Cosurfactant -Labrasol
 The quantity of each content will be taken
according to the pseudo ternary phase
diagram
 This diagram is very essential in
manipulation of ingredients in the
formulation of SMEDDS
CONSTRUCTION OF PSUEDO TERNARY
PHASE DIAGRAMS:
The pseudoternary phase diagrams of oil, surfactant–
cosurfactant, and water were developed to optimize the
formulation using a water titration method. The mixtures
of oil and surfactant–cosurfactant ratios were diluted with
water in a dropwise addition. Phase diagrams were constructed
in the presence of drug to obtain the optimum concentrations
of oil, surfactant, and cosurfactant. SMEDDS form fine oil–
water emulsions upon addition to an aqueous media under
gentle agitation.
Pseudo ternary phase diagram
The gray area indicates the microemulsion region
formulation
Four self-microemulsifying formulations were prepared
using mixtures of oils, surfactants, and cosurfactants in
various proportions. The self-microemulsification
properties, droplet size, and zeta potential of these
formulations were studied upon dilution with water. The
optimized liquid SMEDDS formulation was converted
into free flowing powder by adsorbing onto a solid
carrier for encapsulation.
images of pure drug substance (left), solid SMEDDS
(right; magnification
Dissolution studies
 The dissolution characteristics of solid
intermediates of SMEDDS filled into hard gelatin
capsules was investigated and compared with
liquid formulation and commercial formulation
to ascertain the impact on self-emulsifying
properties following conversion.
Results
 The results indicated that solid intermediates showed
comparable rate and extent of drug dissolution in a
discriminating dissolution medium as liquid SMEDDS
indicating that the self-emulsifying properties of
SMEDDS were unaffected following conversion. Also,
the rate and extent of drug dissolution for solid
intermediates was significantly higher than commercial
tablet formulation. The results from this study
demonstrate the potential use of SMEDDS as a means of
improving solubility, dissolution, and concomitantly the
bioavailability.
Comparision of dissolution studies
CONCLUSION
A SMEDDS formulation of a poorly water-soluble drug,
candesartan cilexetil was formulated for direct filling into
hardgelatin capsules for oral administrationshowed faster rate
of drug release than the marketed product in
a discriminating dissolution media. The results from this
study
demonstrate the utility of SMEDDS to enhance solubility and
dissolution of sparingly soluble compounds like candesartan
which may result in improved therapeutic performance
Advantages
 Protection of sensitive drug substances.
 The emulsion droplets will deliver the drug to GI mucosa in
dissolved state readily accessible for absorption
 When a polymer is incorporated in terms of SMEDDS it
gives prolonged release of medicament
 They are comprised of aqueous and oily components and
therfore can accommodate both hydrophilic aswell as
lipophylic drugs
Disadvantages
 Chemical instabilities
 Irritates GIT
 Precipitation of the lipophilic drugs
 Physical and chemical changes in
crystalline solid in Cryogenic grinding
REFERENCES
 1. Robinson JR. Introduction: semi-solid formulations for oral
drug delivery. Bull Tech Gattefosse. 1996;89:11–3
 2. Aungst BJ. Novel formulation strategies for improving oral
bioavailability of drugs with poor membrane permeation or
presystemic metabolism. J Pharm Sci. 1993;82:979–87.
 3. Constantinides PP. Lipid microemulsions for improving drug
dissolution and oral absorption: physical and biopharmaceutical
aspects. Pharm Res. 1995;12:1561–72.
 4. Pouton CW. Formulation of self-emulsifying drug delivery
systems.
Thank you….
APTI
 T.siva
 APTI/ASSN-1164
 RAN
 1166
 9032796522-PRASANTHI